- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/025 - Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Patent holdings for IPC class C07K 14/025
Total number of patents in this class: 407
10-year publication summary
|
26
|
21
|
44
|
11
|
40
|
21
|
19
|
18
|
24
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sinocelltech Ltd. | 81 |
27 |
| Xiamen University | 589 |
20 |
| Inovio Pharmaceuticals, Inc. | 305 |
18 |
| Xiamen Innovax Biotech Co., Ltd. | 115 |
18 |
| The Trustees of the University of Pennsylvania | 4448 |
13 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3034 |
10 |
| The Johns Hopkins University | 5967 |
7 |
| Janssen Vaccines & Prevention B.V. | 262 |
7 |
| Beijing Health Guard Biotechnology, Inc. | 12 |
7 |
| Inventprise, Inc. | 47 |
7 |
| Baylor College of Medicine | 1022 |
6 |
| The Council of the Queensland Institute of Medical Research | 167 |
5 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 120 |
5 |
| Elicio Therapeutics Inc. | 32 |
5 |
| Defence Therapeutics Inc. | 57 |
5 |
| Vidamune B.V. | 5 |
5 |
| Aura Biosciences, Inc. | 28 |
4 |
| Baylor Research Institute | 217 |
4 |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 37 |
4 |
| Deutsches Krebsforschungszentrum | 396 |
4 |
| Other owners | 226 |